BioE PhD Defense Announcement: Qingfen Pan

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Monday March 9, 2015 - Tuesday March 10, 2015
      12:00 pm - 1:59 pm
  • Location: 2229 ES&T
  • Phone:
  • URL:
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact

Laura Paige

404-385-6655

Summaries

Summary Sentence: "24R,25-dihydroxyvitamin D3 based Therapy for the Treatment of Knee Osteoarthritis"

Full Summary: PhD Defense Presentation- "24R,25-dihydroxyvitamin D3 based Therapy for the Treatment of Knee Osteoarthritis"- Qingfen Pan

Advisor: Barbara Boyan, Ph.D.

 Thesis Committee Members:

Julia Babensee, Ph.D.

Manu Platt, Ph.D.

Brandon Dixon, Ph.D.

Zvi Schwartz, DMD, Ph.D.

 Title: 24R,25-dihydroxyvitamin D3 based Therapy for the Treatment of Knee Osteoarthritis

Osteoarthritis (OA) is the most common degenerative joint disease, which according to the center for disease control (CDC), affects nearly 30 million people in the United States. The disease is characterized by joint inflammation, which leads to chondrocyte apoptosis, cartilage matrix degradation, loss of joint function, and eventually total knee replacement. Current drug therapies aim to ease pain and reduce local inflammation; however, no drug exists that effectively alleviates the disease condition without significant side effects that are typical to anti-inflammatory drugs. Therefore, an unmet medical demand exists for development of tissue-engineering strategies to promote articular cartilage repair and regeneration to treat OA. 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] is an attractive option for articular cartilage repair because of its anti-apoptotic properties in cartilage cells. The overall objective of this work was to prevent degeneration of articular cartilage through the development of a 24R,25(OH)2D3 based therapy, enhancing chondrocyte survival and cartilage repair. The central hypothesis was that 24R,25(OH)2D3 has therapeutic effects on osteoarthritic articular chondrocytes, reducing cell apoptosis and factors contributing to joint inflammation and  cartilage degradation, thus promoting articular cartilage repair and regeneration.

 

Additional Information

In Campus Calendar
No
Groups

Bioengineering Graduate Program

Invited Audience
Undergraduate students, Faculty/Staff, Graduate students
Categories
Other/Miscellaneous
Keywords
No keywords were submitted.
Status
  • Created By: Laura Paige
  • Workflow Status: Published
  • Created On: Feb 23, 2015 - 11:07am
  • Last Updated: Apr 13, 2017 - 5:19pm